Results 261 to 270 of about 123,311 (332)

The National Landscapes of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: Stable Trends in Black Populations and Late-Stage Tumors. [PDF]

Cancers (Basel)
Abboud Y, Pirquet C, Timmons K, Abboud I, Awadallah M, Al-Khazraji A, Hajifathalian K.   +6 more
europepmc   +1 more source

Axillary Reactive Lymphoid Hyperplasia, Likely Due to Unicentric Castleman Disease, and the Concurrent Presence of Orbital Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma: A Six-Year Follow-Up Study. [PDF]

Cureus
Matsuo T, Tanaka T, Fuji T, Ennishi D.
europepmc   +1 more source

Investigating the shared genetic basis and causal relationships between mucosa-associated lymphoid tissue inflammation and psychiatric disorders. [PDF]

Front Psychiatry
Georgiou AN, Voskarides K, Zanos P, Chatzittofis A.   +3 more
europepmc   +1 more source

A rare case report of lung mucosa-associated lymphoid tissue (MALT) lymphoma

Asian Journal of Surgery
XinWei Ya, XiangPeng Zhao, XinYu Lei, ZiXuan Kong   +3 more
doaj  

Some of the next articles are maybe not open access.

Related searches:

Malignant lymphoma of mucosa‐associated lymphoid tissue

Histopathology, 1987
Lymphomas of the gastrointestinal tract, salivary glands, lung and thyroid are grouped together as tumours arising in mucosa‐associated lymphoid tissue. The great majority of them are of B‐cell origin but distinctive T‐cell lymphomas are also recognized in the gastrointestinal tract.
Jo Spencer, Peter G. Isaacson
openaire   +3 more sources

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

Ca-A Cancer Journal for Clinicians, 2016
Answer questions and earn CME ...
Markus Raderer, Barbara Kiesewetter, Andrés J M Ferreri   +2 more
exaly   +2 more sources

Efficacy of eradication therapy in Helicobacter pylori‐negative gastric mucosa‐associated lymphoid tissue lymphoma: A meta‐analysis

Helicobacter, 2021
The role of eradication therapy in Helicobacter pylori‐negative gastric mucosa‐associated lymphoid tissue (MALT) lymphoma remains controversial. The aim of this study was to investigate the efficacy of H.
K. Jung, D. Kim, H. Seo, E. Gong, C. S. Bang   +4 more
semanticscholar   +1 more source

Immunomodulatory treatment for mucosa‐associated lymphoid tissue lymphoma (MALT lymphoma)

Hematological Oncology, 2020
The pathogenesis of mucosa‐associated lymphoid tissue (MALT) lymphoma has been characterized as a dynamic process driven by lymphoma cell dependency on T‐cell signaling, chronic antigenic stimulation of marginal zone B‐cells and activation of the nuclear
B. Kiesewetter, M. Raderer
semanticscholar   +1 more source

Mucosa-associated lymphoid tissue lymphomas

Current Oncology Reports, 2000
Mucosa-associated lymphoid tissue (MALT) lymphoma has attracted attention because its concept has amalgamated the study of etiology and pathogenesis in an intriguing group of lymphomas. MALT lymphomas are a B-cell malignancy with characteristic lymphoepithelial lesions; cells are CD20-positive and CD5- and CD10-negative.
Mary Gospodarowicz, Richard W. Tsang
openaire   +3 more sources

Mucosa-associated lymphoid tissue lymphoma

Current Opinion in Hematology, 2002
Since the first description of mucosa-associated lymphoid tissue (MALT) lymphoma in 1983 rapid advances have been made in the understanding of the pathogenesis and underlying molecular events associated with the development of this tumor. Lymphoma arises at extranodal sites in which a pre-existing inflammatory response has provoked the acquisition of ...
Andrew Wotherspoon, Ming-Qing Du, Ahmet Dogan   +2 more
openaire   +3 more sources